Norethindrone And Ethinyl Estradiol And Ferrous Fumarate Kit
Product Images NDC 0378-7297

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norethindrone And Ethinyl Estradiol And Ferrous Fumarate (NDC 0378-7297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecule (0f7238df 814e 4726 Bb00 5e3451351af1 01)

Chemical structures of the active ingredients norethindrone and ethinyl estradiol. The image depicts the steroidal molecular frameworks characteristic of these two compounds, with labeled chemical groups and bonds.*

FDA Label Image

Graph (0f7238df 814e 4726 Bb00 5e3451351af1 02)

A chart depicting pregnancy rates per 100 women in one year associated with different birth control methods. The vertical axis shows 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom, with labels for pregnancy rates ranging from fewer than 1 to 85 or more per 100 women. Various contraceptive methods are grouped in boxes along this axis, from most to least effective, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, spermicide, withdrawal, abstinence during fertile days, and no birth control.*

FDA Label Image

Blister Pack (0f7238df 814e 4726 Bb00 5e3451351af1 03)

Label panel for a 28-tablet kit of Norethindrone and Ethinyl Estradiol and Ferrous Fumarate chewable tablets, 0.4 mg/0.035 mg strength, by Mylan Pharmaceuticals Inc. The layout shows a 4-week cycle with active tablets indicated for weeks 1-3 and inactive for week 4, organized by days of the week from Sunday to Saturday.*

FDA Label Image

Blister With Hand (0f7238df 814e 4726 Bb00 5e3451351af1 04)

An instructional illustration showing hands holding a blister pack of tablets. Two arrows point downward to indicate the removal or dispensing of tablets from the pack, likely demonstrating how to access the medication in the kit.*

FDA Label Image

Image 01

Norethindrone and Ethinyl Estradiol and Ferrous Fumarate tablets kit from Mylan Pharmaceuticals Inc., with active ingredients norethindrone 0.4 mg and ethinyl estradiol 0.035 mg per yellow tablet, and ferrous fumarate 75 mg per brown tablet. The packaging indicates a total count of 28 tablets, including 21 yellow and 7 brown tablets, designed as chewable tablets. The label includes dosage information and manufacturer details, with a predominantly orange background.*

FDA Label Image

Image 02

A forest plot chart showing effect estimates (Odds Ratios/Relative Risks) with confidence intervals from eight different studies related to contraceptive use, including NICHD Women's Contraceptive Study (2002), French E3N cohort Study (2005), Shangai Women’s Health Study (2009), Nurses’ Health Study II (2010), Oxford Family Planning Association Study (2013), and Danish Sex Hormone Register Study (2017). The horizontal axis represents effect estimates ranging from approximately -1.5 to 2.0, with a vertical reference line at 1.0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.